Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H26FN3O2 |
Molecular Weight | 395.4698 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)C4=CC=CC=C4
InChI
InChIKey=DKGZKTPJOSAWFA-UHFFFAOYSA-N
InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18786164 | https://www.ncbi.nlm.nih.gov/pubmed/10202608 | https://www.ncbi.nlm.nih.gov/pubmed/8866760
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18786164 | https://www.ncbi.nlm.nih.gov/pubmed/10202608 | https://www.ncbi.nlm.nih.gov/pubmed/8866760
Spiperone (Spiroperidol; brand name: Spiropitan (JP)) is a typical antipsychotic and research chemical belonging to the butyrophenone chemical class. Spiperone is selective D2 dopamine receptor antagonist; α1B-adrenoceptor antagonist; mixed 5-HT2A/5-HT1 serotonin receptor antagonist. Additionally, spiperone was identified by compound screening to be an activator of Ca2+ activated Cl− channels (CaCCs), thus a potential target for therapy of cystic fibrosis. Spiperone is widely used as a pharmacological tool for studying neurotransmitter receptors.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26227779 |
1.08 nM [Ki] | ||
Target ID: CHEMBL219 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23403082 |
0.2 nM [Ki] | ||
Target ID: CHEMBL234 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26227779 |
0.48 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats. | 1975 |
|
Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy. | 1975 Jan-Feb |
|
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum. | 2001 |
|
Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer. | 2001 |
|
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. | 2001 |
|
Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins. | 2001 |
|
Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment. | 2001 Apr |
|
The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice. | 2001 Apr |
|
Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. | 2001 Apr |
|
Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. | 2001 Apr 20 |
|
D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. | 2001 Apr 27 |
|
Cis- and trans-N-benzyl-octahydrobenzo[g]quinolines. Adrenergic and dopaminergic activity studies. | 2001 Apr 9 |
|
Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype. | 2001 Aug 3 |
|
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. | 2001 Feb |
|
Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635. | 2001 Jan |
|
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain. | 2001 Jan 31 |
|
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes. | 2001 Jun |
|
Stimulation of sodium-dependent inorganic phosphate transport by activation of Gi/o-protein-coupled receptors by epinephrine in MC3T3-E1 osteoblast-like cells. | 2001 Jun |
|
The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. | 2001 Jun |
|
Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. | 2001 Jun |
|
Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). | 2001 Mar |
|
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors. | 2001 Mar |
|
S 14506: novel receptor coupling at 5-HT(1A) receptors. | 2001 Mar |
|
Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells. | 2001 Mar-Apr |
|
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. | 2001 May |
|
Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. | 2001 May 25 |
|
Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice. | 2001 Nov |
|
Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma. | 2001 Nov 30 |
|
Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. | 2001 Sep |
|
Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice. | 2001 Sep |
|
Benzamide bioisosteres incorporating dihydroheteroazole substructures: EPC synthesis and SAR leading to a selective dopamine D4 receptor partial agonist (FAUC 179). | 2001 Sep 17 |
|
New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities. | 2001 Sep 3 |
|
Occurrence of dopaminergic (D(2)) receptors within the rabbit pulmonary circulation. | 2002 |
|
Atmospheric pressure laser desorption/chemical ionization mass spectrometry: a new ionization method based on existing themes. | 2002 |
|
Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats. | 2002 Aug |
|
Functional cooperation between neurosteroids and D2 dopamine antagonists on KCl-evoked [3H]noradrenaline release: modulation by calcium channel blockers. | 2002 Dec |
|
Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors. | 2002 Feb-Nov |
|
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. | 2002 Jul |
|
Functional screening of G protein-coupled receptors by measuring intracellular calcium with a fluorescence microplate reader. | 2002 Jun |
|
Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. | 2002 Jun |
|
The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype. | 2002 Mar |
|
Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists. | 2002 May |
|
The effects of dopamine synthesis inhibitors and dopamine antagonists on regeneration in the hydra Hydra attenuata. | 2002 May-Jun |
|
Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. | 2002 Nov |
|
Spreading depression: imaging and blockade in the rat neocortical brain slice. | 2002 Nov |
|
Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells. | 2002 Nov 8 |
|
Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling. | 2002 Sep |
|
Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats. | 2003 |
|
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. | 2003 Feb |
|
Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter. | 2003 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9029505
Rat: i.v. injection 12 mkCi (180 ng).
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10202608
Aliquots of lymphocyte suspension containing 1 x 106- 2 x 106 cells in a final volume of 1.0 mL were incubated in duplicate for 1 hour at 37°C with varying concentrations of 3H-spiperone (0.1—4 nM) in the presence or absence of 10 5 M haloperidol. Cell viability, checked in a number of samples incubated in the absence of 3H-spiperone by their ability to exclude trypan blue, always exceeded 98%. After incubation, the samples were filtered (type GF/B) and rinsed six times with 4 ml cooled buffer B. The filters were dried and transferred to mini-vials with 5 mL hydro-luma scintillation fluid; radioactivity was counted in a liquid scintillation counter.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66558
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
2470
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
m10148
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB10617MIG
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
D013134
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
9233
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
170983
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
DTXSID5045205
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
212-024-0
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL267930
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
1553
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
SPIPERONE
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
749-02-0
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
5265
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
100000083802
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY | |||
|
4X6E73CJ0Q
Created by
admin on Fri Dec 15 15:50:37 GMT 2023 , Edited by admin on Fri Dec 15 15:50:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY